Bernard A. Fox, Co – founder, President, and CEO of UbiVac, shared Patrick Hwu’s, President and CEO at Moffitt Cancer Center, post by Poh Sheng Joe, Associate Professor of Duke-NUS Medical School, adding:
“Prof. Poh Sheng Joe Yeong – Thanks for your leadership in pulling together the “movers and shakers” in cancer immunotherapy that are based in the Asian-Pacific region. This third annual conference, in coordination with the Taiwan Oncology Society (TOS) and the Taiwan society for immunotherapy of Cancer (TSITC) was a clear success!
Thanks to the local organizers Drs. John Wen-Cheng Chang, Peter Chiao-en Wu, Jen-Shi Chen, Tom Wei-Wu Chen, Huey-En Tzeng, Ming-Huang Chen, as well as Society for Immunotherapy of Cancer (SITC) president James Gulley MD PhD FACP, and Journal for ImmunoTherapy of Cancer Editor-in-Chief, Michael Lotze who also served as organizers.
As Chair of the World Immunotherapy Council (WIC), I am already looking forward to the fourth WIC-APAC that will be held in Thailand. The lead organizer for that meeting will be Dr. Nattiya Hirankarn.”
Quoting Poh Sheng Joe‘s post:
“Asia Pacific touring series.
On this Easter, I look back with gratitude on the successful hosting of the World Immunotherapy Council (WIC) APAC held in Taiwan last week.
WIC APAC serves as a rotating platform across the Asia-Pacific region, bringing together diverse communities while experiencing the unique culture and spirit of each host country. Taiwan this year, Thailand next year, and Japan the year after — I look forward to meeting again.
The value of the Asia-Pacific alliance lies in fostering cross-regional collaboration and dialogue, addressing the unique challenges and opportunities of our region. In today’s complex global landscape, such connection and exchange are especially precious.”
Other articles featuring Bernard A. Fox.
